Search results for "Infectious diseases"


 
Results 51 - 60 of about 299 for "Infectious diseases".
Sort by: Relevance | Newest | Oldest

CDC issues interim guidance on measles infection control and prevention in health care

New government guidance covers what is acceptable evidence of immunity to measles and how to respond if health care personnel are exposed to the disease.
https://immattersacp.org/weekly/archives/2019/07/30/4.htm
30 Jul 2019

Latest research looks at prolonged symptoms, drug treatments in COVID-19

Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021

Oral lefamulin noninferior to oral moxifloxacin in treating community-acquired bacterial pneumonia

Approved by the FDA in August, lefamulin is an “important addition to the current antibiotic armamentarium,” although barriers to use will likely include cost and tolerability concerns, an editor's note said.
https://immattersacp.org/weekly/archives/2019/10/01/2.htm
1 Oct 2019

Certain factors associated with higher mortality risk in invasive group B strep infection

In a study of patients with invasive group B Streptococcus infections, all-cause 30-day mortality was highest for those with peritonitis and pneumonia or empyema and lowest among those with osteomyelitis or joint infection.
https://immattersacp.org/weekly/archives/2020/01/07/4.htm
7 Jan 2020

DEI or DIE?

The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021

Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research

Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020

IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments

The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020

Joint guidelines on Lyme disease prevention, diagnosis, treatment open for comment

Among other recommendations, the draft guidelines favor oral antibiotic therapy with doxycycline, amoxicillin, cefuroxime axetil, or phenoxymethylpenicillin over other antimicrobials for treatment of Lyme disease.
https://immattersacp.org/weekly/archives/2019/07/02/2.htm
2 Jul 2019

COVID-19 outcomes in health care workers and over the long term, vaccine evidence and uptake among the latest research

A study found that health care workers hospitalized with COVID-19 had shorter stays, while a survey showed high uncertainty about vaccination. Johnson & Johnson released efficacy data on a one-shot vaccine, and a study identified long-term decreases in function among COVID-19 survivors.
https://immattersacp.org/weekly/archives/2021/02/02/1.htm
2 Feb 2021

COVID-19 research covers taste and smell alterations, incidence in nursing homes and shelters, resource allocation policies

Other topics of note this week include guidance from the Infectious Diseases Society of America (IDSA) on personal protective equipment, plus information from the FDA and IDSA on serum antibody tests.
https://immattersacp.org/weekly/archives/2020/04/28/1.htm
28 Apr 2020

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next